Biotech company Orgenesis Inc. has made significant strides in the global cell and gene therapies sector with its innovative Point of Care (POCare) platform. The company's POCare technology system facilitates the development of licensed therapeutics, which are produced using closed automated systems within a collaborative network. With a focus on autologous therapies, Orgenesis tailors its approach to suit each individual therapy, employing validated closed and automated processing systems that comply with industry regulations. The Germantown, Maryland-based company was previously known as Business Outsourcing Service, Inc. before rebranding itself as Orgenesis Inc. in 2011. Founded in 2008, Orgenesis has become a leading contender in the biotech sector with its cutting-edge technology and patient-centric approach.
Orgenesis's ticker is ORGS
The company's shares trade on the NASDAQ stock exchange
They are based in Germantown, Maryland
There are 201-500 employees working at Orgenesis
It is orgenesis.com/#
Orgenesis is in the Healthcare sector
Orgenesis is in the Biotechnology industry
The following five companies are Orgenesis's industry peers: